Section Arrow
SMMT.NASDAQ
- Summit Therapeutics
Quotes are at least 15-min delayed:2026/06/06 11:13 EDT
Regular Hours
Last
 14.77
-0.07 (-0.47%)
Day High 
15.35 
Prev. Close
14.84 
1-M High
19.415 
Volume 
6.52M 
Bid
14.74
Ask
14.84
Day Low
14.655 
Open
15.24 
1-M Low
14.17 
Market Cap 
11.52B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 16.39 
20-SMA 17.01 
50-SMA 18.96 
52-W High 30.98 
52-W Low 13.83 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.59/-0.81
Enterprise Value
11.54B
Balance Sheet
Book Value Per Share
0.70
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BCDABioCardia Inc.1.03+0.111+12.08%-- 
BGMSBio Green Med Solution Inc1.5+0.44+41.51%0.3PE
CMNDClearmind Medicine Inc.3.98+1.07+36.77%-- 
ADTXAditxt Inc.0.0621-0.0149-19.35%-- 
RXRXRecursion Pharmaceuticals3.315-0.485-12.76%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.